Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesAn Infectious Diseases Physician-Led Antimicrobial Stewardship Program at a Small Community Hospital Associated With Improved Susceptibility Patterns and Cost-Savings After the First YearLeveraging antimicrobial stewardship into improving rates of carbapenem-resistant EnterobacteriaceaeThe Whole Price of Vancomycin: Toxicities, Troughs, and TimeCarbapenem-resistant Enterobacteriaceae: epidemiology and prevention.Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.Rapid intrinsic fluorescence method for direct identification of pathogens in blood cultures.Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospitalManagement of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States.Antimicrobial stewardship: attempting to preserve a strategic resource.Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaCarbapenem Restriction and its Effect on Bacterial Resistance in an Intensive Care unit of a Teaching Hospital.Compensation of fitness costs and reversibility of antibiotic resistance mutations.Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.Antimicrobial stewardship programs in community hospitals: the evidence base and case studies.When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model.Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study.Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.Benchmarking antimicrobial drug use in hospitals.Impact of formulary restriction with prior authorization by an antimicrobial stewardship program.Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010.The role of antimicrobial stewardship in curbing carbapenem resistance.In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women's and children's hospital, Singapore.Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012.Evaluation of a Computerized Decision Support Intervention to Decrease Use of Anti-Pseudomonal Carbapenems in Penicillin Allergic Patients.Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin.Distribution and drug resistance of pathogenic bacteria isolated from cancer hospital in 2013.Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation.Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.Impact of requiring re-authorization of restricted antibiotics on day 3 of therapy.Correlation between carbapenem consumption and antimicrobial resistance rates of Acinetobacter baumannii in a university-affiliated hospital in China.Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli.
P2860
Q26799580-7161875C-25FD-42BF-A779-3F3BE16B1932Q30279117-EBE5A9D5-2D65-432D-A513-843E628F594BQ33816217-B53DEA38-0400-4BB8-98D9-705E467DBC8EQ33885191-63088DCA-8A39-453F-9EB0-67B81B951EE4Q34190800-ACA5C570-BC1D-4A44-BB44-A3C2CA3FB9EBQ34311384-7F76ED5C-E638-4248-9A6A-5FB6EF6EC712Q35047371-801D7659-2E0F-4941-9E09-83EE0DC0699FQ35229009-2000C6F9-98A7-410A-9D28-DF7849DCF9CFQ36078359-D76E6D22-FC1A-4638-B7FD-86B584137CA4Q36281068-5308D850-0404-4F64-BE89-93B2CE26C1A6Q37021239-5525FC02-FEFB-4BE8-AA46-3D6AE85D21BEQ37220711-D065D1AA-0B1C-4991-BDAB-0DCDD8934458Q37268544-BE34E4B9-EFFF-4296-A34C-0D0DBBC19712Q37696851-7A0FA5BC-4DF9-41ED-ABE5-6E17EF758F3DQ37771799-4932F623-16BA-4EA2-81CD-5E3AED244C94Q37906969-F48E2B09-C804-43F5-B976-AA5A6EB7FE5BQ37907967-C5AD02C1-3FB2-465E-A7BD-EB0E14A4D411Q37933361-126A0604-A534-4371-BC8C-359C71C8DA5FQ37989854-625F8328-6DAC-4CE2-9F07-A4CE64D0EEBEQ37993716-C8425653-27EF-44E0-A98F-F3701650B077Q38003493-DC3431CB-C80F-40E8-A8E9-5CA421BA3FDBQ38060050-8F260C60-E7C0-475E-B8C6-C5968948D718Q38087566-675B120B-1424-4D5F-9742-5D00C36D9802Q38125493-C2981F29-3E7F-48AD-8050-3826C0F146A2Q38626867-2CA2EAD8-4854-4325-BA87-79DBA347B070Q39118511-782CEF08-CCB2-416F-BE6D-B051557F7036Q39179477-10A5797E-55B8-4D97-85AC-43EF47416844Q39594331-E309AB7E-5842-41CC-8ED8-E9C684794E88Q41202710-E02BAF7E-A2EE-4DEB-83DD-B28AF12A328CQ41561781-F5759B0E-3D9E-4B8A-B060-2B80B27D0F55Q42278017-03B7585A-B01A-45DE-A1F1-40DEA1713FACQ44022634-A537D71F-7398-494B-9A1F-C9404E22CF73Q47145788-BFEDC95D-FB45-4965-9C2B-0956466F03C2Q47898746-C69E6B2D-6AC1-48AF-8AE1-D8654AD19F72Q50097050-2CAB7A1E-0EF6-4F2B-B619-B1DE4E5A38CEQ50872389-E1F15B9A-CF26-4522-9039-FB9970BBFAAEQ51034635-3476C0CD-1B67-4878-A6E9-1C295ED85ED1Q54346349-0DAF4A62-F63C-4378-A053-C3FC00017F1F
P2860
Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relationship of carbapenem res ...... sistant Pseudomonas aeruginosa
@en
Relationship of carbapenem res ...... istant Pseudomonas aeruginosa.
@nl
type
label
Relationship of carbapenem res ...... sistant Pseudomonas aeruginosa
@en
Relationship of carbapenem res ...... istant Pseudomonas aeruginosa.
@nl
prefLabel
Relationship of carbapenem res ...... sistant Pseudomonas aeruginosa
@en
Relationship of carbapenem res ...... istant Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
Relationship of carbapenem res ...... sistant Pseudomonas aeruginosa
@en
P2093
Amy L Pakyz
Michael Oinonen
Ronald E Polk
P2860
P304
P356
10.1128/AAC.01535-08
P407
P577
2009-03-09T00:00:00Z